Cumberland Pharmaceuticals (CPIX) Reports Q2 EPS of $0.09

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.09, versus $0.10 reported last year. Revenue for the quarter came in at $8.9 million, versus $9.8 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits